Leigh Anne Dageforde, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Liver Transplantation | 20 | 2024 | 2325 | 4.370 |
Why?
|
Tissue and Organ Procurement | 9 | 2024 | 944 | 2.790 |
Why?
|
Carcinoma, Hepatocellular | 8 | 2024 | 2299 | 1.610 |
Why?
|
Waiting Lists | 8 | 2024 | 763 | 1.590 |
Why?
|
Liver Neoplasms | 8 | 2024 | 4319 | 1.280 |
Why?
|
Organ Transplantation | 4 | 2022 | 1150 | 1.220 |
Why?
|
Living Donors | 5 | 2023 | 636 | 1.050 |
Why?
|
End Stage Liver Disease | 5 | 2024 | 353 | 1.050 |
Why?
|
Health Literacy | 4 | 2015 | 440 | 1.040 |
Why?
|
Hepatitis, Alcoholic | 2 | 2024 | 109 | 0.970 |
Why?
|
Kidney Transplantation | 7 | 2024 | 4214 | 0.960 |
Why?
|
Cholangiocarcinoma | 2 | 2020 | 548 | 0.930 |
Why?
|
Bezoars | 1 | 2023 | 29 | 0.870 |
Why?
|
Tissue Donors | 8 | 2023 | 2314 | 0.870 |
Why?
|
Kidney Failure, Chronic | 6 | 2023 | 2470 | 0.720 |
Why?
|
Neoplasms, Complex and Mixed | 1 | 2020 | 35 | 0.720 |
Why?
|
Students, Medical | 3 | 2024 | 1927 | 0.680 |
Why?
|
Patients | 2 | 2015 | 906 | 0.610 |
Why?
|
Hepatectomy | 2 | 2020 | 559 | 0.600 |
Why?
|
Motor Vehicles | 1 | 2020 | 281 | 0.600 |
Why?
|
Graft Survival | 8 | 2023 | 3795 | 0.590 |
Why?
|
Clinical Clerkship | 1 | 2024 | 563 | 0.590 |
Why?
|
Renal Dialysis | 4 | 2023 | 1801 | 0.530 |
Why?
|
Motivation | 2 | 2024 | 1993 | 0.530 |
Why?
|
Brachiocephalic Veins | 1 | 2014 | 21 | 0.480 |
Why?
|
Education, Medical, Undergraduate | 1 | 2024 | 1066 | 0.470 |
Why?
|
Fellowships and Scholarships | 1 | 2023 | 1116 | 0.460 |
Why?
|
Absenteeism | 1 | 2015 | 250 | 0.450 |
Why?
|
Ultrasonography, Doppler, Duplex | 1 | 2014 | 200 | 0.440 |
Why?
|
Writing | 1 | 2015 | 199 | 0.440 |
Why?
|
Bile Duct Neoplasms | 1 | 2019 | 601 | 0.440 |
Why?
|
Weight Loss | 1 | 2024 | 2684 | 0.410 |
Why?
|
Patient Participation | 1 | 2021 | 1439 | 0.410 |
Why?
|
Biliary Tract Surgical Procedures | 1 | 2012 | 45 | 0.400 |
Why?
|
Mesenteric Artery, Superior | 1 | 2012 | 95 | 0.400 |
Why?
|
Women, Working | 1 | 2012 | 86 | 0.400 |
Why?
|
Bile Duct Diseases | 1 | 2012 | 97 | 0.390 |
Why?
|
Career Choice | 2 | 2021 | 754 | 0.390 |
Why?
|
Health Knowledge, Attitudes, Practice | 3 | 2015 | 3985 | 0.380 |
Why?
|
Arteriovenous Shunt, Surgical | 1 | 2014 | 294 | 0.370 |
Why?
|
Nephrectomy | 2 | 2018 | 1016 | 0.370 |
Why?
|
Bile Ducts | 1 | 2012 | 282 | 0.360 |
Why?
|
Brain Death | 2 | 2023 | 356 | 0.360 |
Why?
|
Personnel Selection | 1 | 2012 | 193 | 0.360 |
Why?
|
Aneurysm, False | 1 | 2012 | 257 | 0.340 |
Why?
|
Catheters, Indwelling | 1 | 2012 | 428 | 0.340 |
Why?
|
Upper Extremity | 1 | 2014 | 661 | 0.330 |
Why?
|
Thrombosis | 1 | 2023 | 3051 | 0.320 |
Why?
|
Policy | 2 | 2023 | 511 | 0.320 |
Why?
|
Health Care Costs | 2 | 2012 | 3258 | 0.320 |
Why?
|
Iatrogenic Disease | 1 | 2012 | 538 | 0.320 |
Why?
|
Physician-Patient Relations | 1 | 2021 | 3242 | 0.300 |
Why?
|
Specialties, Surgical | 1 | 2012 | 388 | 0.300 |
Why?
|
Models, Economic | 1 | 2012 | 719 | 0.300 |
Why?
|
Registries | 2 | 2024 | 8458 | 0.300 |
Why?
|
Body Mass Index | 2 | 2024 | 12914 | 0.290 |
Why?
|
Catheterization, Central Venous | 1 | 2012 | 526 | 0.280 |
Why?
|
Internship and Residency | 3 | 2023 | 5870 | 0.280 |
Why?
|
Physicians, Women | 1 | 2012 | 495 | 0.270 |
Why?
|
Physicians | 1 | 2024 | 4591 | 0.260 |
Why?
|
Humans | 50 | 2024 | 760613 | 0.250 |
Why?
|
Liver | 4 | 2023 | 7510 | 0.250 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2023 | 9278 | 0.240 |
Why?
|
Retrospective Studies | 18 | 2024 | 80345 | 0.240 |
Why?
|
Adult | 23 | 2024 | 220007 | 0.230 |
Why?
|
Vascular Surgical Procedures | 1 | 2012 | 1469 | 0.230 |
Why?
|
Anastomosis, Roux-en-Y | 1 | 2023 | 86 | 0.220 |
Why?
|
Organ Preservation | 2 | 2023 | 379 | 0.200 |
Why?
|
Abdominal Muscles | 1 | 2023 | 170 | 0.200 |
Why?
|
Acute Kidney Injury | 2 | 2024 | 1941 | 0.200 |
Why?
|
Donor Selection | 1 | 2023 | 228 | 0.190 |
Why?
|
Patient Acceptance of Health Care | 1 | 2015 | 3164 | 0.190 |
Why?
|
Hepatitis C | 3 | 2020 | 1579 | 0.190 |
Why?
|
Hemostasis | 1 | 2023 | 468 | 0.180 |
Why?
|
Academies and Institutes | 1 | 2022 | 319 | 0.180 |
Why?
|
Postoperative Complications | 6 | 2018 | 15679 | 0.170 |
Why?
|
Anastomosis, Surgical | 1 | 2023 | 983 | 0.170 |
Why?
|
Logistic Models | 3 | 2023 | 13312 | 0.160 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2013 | 2290 | 0.160 |
Why?
|
Perfusion | 1 | 2023 | 1376 | 0.160 |
Why?
|
Chi-Square Distribution | 2 | 2015 | 3465 | 0.160 |
Why?
|
Hand-Assisted Laparoscopy | 1 | 2018 | 16 | 0.150 |
Why?
|
Male | 24 | 2024 | 359718 | 0.150 |
Why?
|
Middle Aged | 19 | 2024 | 220359 | 0.150 |
Why?
|
Quality-Adjusted Life Years | 3 | 2013 | 1723 | 0.140 |
Why?
|
Aged | 13 | 2024 | 169143 | 0.140 |
Why?
|
Kaplan-Meier Estimate | 2 | 2020 | 6544 | 0.140 |
Why?
|
Biliary Tract Diseases | 1 | 2018 | 157 | 0.140 |
Why?
|
Liver Cirrhosis | 2 | 2024 | 1931 | 0.140 |
Why?
|
Abdomen | 1 | 2023 | 1130 | 0.140 |
Why?
|
Survival Rate | 4 | 2024 | 12810 | 0.140 |
Why?
|
Health Expenditures | 2 | 2024 | 2362 | 0.140 |
Why?
|
Education, Medical, Graduate | 2 | 2023 | 2363 | 0.130 |
Why?
|
Resource Allocation | 1 | 2018 | 349 | 0.130 |
Why?
|
Counseling | 1 | 2024 | 1548 | 0.130 |
Why?
|
Educational Status | 1 | 2024 | 2514 | 0.130 |
Why?
|
Focus Groups | 1 | 2021 | 1378 | 0.130 |
Why?
|
Liver Failure | 1 | 2018 | 249 | 0.130 |
Why?
|
Female | 23 | 2024 | 391246 | 0.130 |
Why?
|
Severity of Illness Index | 5 | 2024 | 15840 | 0.130 |
Why?
|
User-Computer Interface | 1 | 2021 | 1403 | 0.120 |
Why?
|
Tumor Burden | 1 | 2020 | 1895 | 0.120 |
Why?
|
Pancreatectomy | 1 | 2019 | 810 | 0.120 |
Why?
|
Tennessee | 1 | 2014 | 119 | 0.120 |
Why?
|
Healthcare Disparities | 2 | 2024 | 3386 | 0.120 |
Why?
|
Program Evaluation | 2 | 2013 | 2493 | 0.120 |
Why?
|
Time Factors | 6 | 2024 | 40139 | 0.110 |
Why?
|
Cost of Illness | 1 | 2024 | 1940 | 0.110 |
Why?
|
Decision Trees | 2 | 2013 | 506 | 0.110 |
Why?
|
Personnel Staffing and Scheduling | 2 | 2018 | 498 | 0.110 |
Why?
|
Disease-Free Survival | 2 | 2020 | 6831 | 0.110 |
Why?
|
Death | 1 | 2018 | 678 | 0.110 |
Why?
|
Hepatitis B | 1 | 2018 | 701 | 0.110 |
Why?
|
Obesity | 3 | 2024 | 12919 | 0.110 |
Why?
|
United States | 8 | 2024 | 72448 | 0.100 |
Why?
|
Quality of Life | 4 | 2024 | 13308 | 0.100 |
Why?
|
Cost-Benefit Analysis | 4 | 2013 | 5508 | 0.100 |
Why?
|
Peritoneal Dialysis | 1 | 2013 | 157 | 0.100 |
Why?
|
Multivariate Analysis | 3 | 2015 | 12159 | 0.100 |
Why?
|
Markov Chains | 2 | 2013 | 968 | 0.100 |
Why?
|
Costs and Cost Analysis | 1 | 2018 | 1677 | 0.100 |
Why?
|
Hypertension | 1 | 2012 | 8595 | 0.100 |
Why?
|
Decision Support Techniques | 2 | 2012 | 2001 | 0.100 |
Why?
|
Treatment Outcome | 6 | 2022 | 64981 | 0.100 |
Why?
|
Hepatitis C, Chronic | 1 | 2020 | 1031 | 0.100 |
Why?
|
Patient Selection | 1 | 2023 | 4279 | 0.100 |
Why?
|
Models, Econometric | 1 | 2012 | 216 | 0.100 |
Why?
|
Vascular Patency | 1 | 2014 | 901 | 0.090 |
Why?
|
Sick Leave | 1 | 2012 | 105 | 0.090 |
Why?
|
Prognosis | 4 | 2024 | 29661 | 0.090 |
Why?
|
Thigh | 1 | 2012 | 240 | 0.090 |
Why?
|
Socioeconomic Factors | 2 | 2015 | 7805 | 0.090 |
Why?
|
Antiviral Agents | 2 | 2020 | 3061 | 0.090 |
Why?
|
Burnout, Professional | 1 | 2018 | 702 | 0.090 |
Why?
|
Perception | 1 | 2015 | 1195 | 0.080 |
Why?
|
Catheterization | 1 | 2013 | 1432 | 0.080 |
Why?
|
Treatment Failure | 1 | 2014 | 2647 | 0.080 |
Why?
|
Survival Analysis | 2 | 2019 | 10185 | 0.070 |
Why?
|
Exercise | 1 | 2024 | 5787 | 0.070 |
Why?
|
Angiography | 1 | 2012 | 1605 | 0.070 |
Why?
|
Monte Carlo Method | 1 | 2012 | 1257 | 0.070 |
Why?
|
Workload | 1 | 2012 | 847 | 0.070 |
Why?
|
Cost Savings | 1 | 2012 | 920 | 0.070 |
Why?
|
Delivery of Health Care | 1 | 2024 | 5325 | 0.060 |
Why?
|
Hospital Costs | 1 | 2012 | 976 | 0.060 |
Why?
|
Employment | 1 | 2012 | 1112 | 0.060 |
Why?
|
Child | 4 | 2023 | 79799 | 0.060 |
Why?
|
Preoperative Care | 1 | 2014 | 2255 | 0.060 |
Why?
|
Iron | 1 | 2013 | 1786 | 0.060 |
Why?
|
Risk Factors | 6 | 2024 | 74333 | 0.060 |
Why?
|
Hospitalization | 1 | 2024 | 10789 | 0.060 |
Why?
|
Early Detection of Cancer | 1 | 2018 | 3202 | 0.060 |
Why?
|
Carcinoma, Renal Cell | 1 | 2019 | 3218 | 0.060 |
Why?
|
Patient Education as Topic | 1 | 2013 | 2315 | 0.050 |
Why?
|
Follow-Up Studies | 1 | 2024 | 39262 | 0.050 |
Why?
|
Oxidative Stress | 1 | 2013 | 3106 | 0.050 |
Why?
|
Kidney Neoplasms | 1 | 2019 | 4312 | 0.050 |
Why?
|
Renal Replacement Therapy | 1 | 2024 | 281 | 0.050 |
Why?
|
Odds Ratio | 1 | 2014 | 9716 | 0.050 |
Why?
|
Reoperation | 1 | 2012 | 4289 | 0.050 |
Why?
|
Pilot Projects | 1 | 2015 | 8556 | 0.050 |
Why?
|
Pancreatic Neoplasms | 1 | 2019 | 5349 | 0.050 |
Why?
|
Laparoscopy | 1 | 2013 | 2147 | 0.050 |
Why?
|
Life Style | 1 | 2012 | 3898 | 0.050 |
Why?
|
Efficiency | 1 | 2024 | 477 | 0.050 |
Why?
|
Cross Infection | 1 | 2009 | 1434 | 0.040 |
Why?
|
Proportional Hazards Models | 1 | 2014 | 12531 | 0.040 |
Why?
|
Sex Factors | 1 | 2012 | 10546 | 0.040 |
Why?
|
Cold Ischemia | 1 | 2018 | 67 | 0.040 |
Why?
|
Predictive Value of Tests | 1 | 2014 | 15286 | 0.040 |
Why?
|
Anti-HIV Agents | 1 | 2013 | 4491 | 0.040 |
Why?
|
Reproducibility of Results | 1 | 2015 | 20080 | 0.040 |
Why?
|
Diagnosis, Differential | 1 | 2012 | 12968 | 0.030 |
Why?
|
Peer Group | 1 | 2022 | 674 | 0.030 |
Why?
|
Disease Progression | 1 | 2013 | 13505 | 0.030 |
Why?
|
Pancreaticoduodenectomy | 1 | 2019 | 508 | 0.030 |
Why?
|
Mentors | 1 | 2021 | 661 | 0.030 |
Why?
|
Intensive Care Units | 1 | 2009 | 3736 | 0.030 |
Why?
|
Appointments and Schedules | 1 | 2018 | 442 | 0.030 |
Why?
|
Adaptation, Psychological | 1 | 2024 | 2628 | 0.030 |
Why?
|
Hepacivirus | 1 | 2020 | 1334 | 0.030 |
Why?
|
Travel | 1 | 2018 | 785 | 0.030 |
Why?
|
Risk Assessment | 1 | 2013 | 24102 | 0.020 |
Why?
|
Equipment Failure | 1 | 2013 | 577 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2012 | 20509 | 0.020 |
Why?
|
Population Surveillance | 1 | 2018 | 2608 | 0.020 |
Why?
|
Poisson Distribution | 1 | 2009 | 507 | 0.020 |
Why?
|
Hemoglobins | 1 | 2013 | 1521 | 0.020 |
Why?
|
Kidney | 1 | 2023 | 7064 | 0.020 |
Why?
|
HIV Infections | 1 | 2013 | 17165 | 0.020 |
Why?
|
Quality Improvement | 1 | 2022 | 3835 | 0.020 |
Why?
|
Catheter-Related Infections | 1 | 2009 | 273 | 0.020 |
Why?
|
Hospitals | 1 | 2018 | 3928 | 0.020 |
Why?
|
Anemia | 1 | 2013 | 1511 | 0.010 |
Why?
|
Databases, Factual | 1 | 2019 | 8022 | 0.010 |
Why?
|
Mass Screening | 1 | 2018 | 5422 | 0.010 |
Why?
|
Pandemics | 1 | 2022 | 8623 | 0.010 |
Why?
|
Bacteremia | 1 | 2009 | 980 | 0.010 |
Why?
|
Health Services Accessibility | 1 | 2018 | 5397 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2009 | 6238 | 0.010 |
Why?
|
Critical Illness | 1 | 2009 | 2709 | 0.010 |
Why?
|
Cohort Studies | 1 | 2018 | 41337 | 0.010 |
Why?
|
Adolescent | 1 | 2022 | 87809 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2013 | 25941 | 0.010 |
Why?
|
Prospective Studies | 1 | 2009 | 54306 | 0.000 |
Why?
|